HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vander Woude, J. C. Articles by Cooley, D. A. Search for Related Content PubMed PubMed Citation Articles by Vander Woude, J. C. Articles by Cooley, D. A.

The Annals of Thoracic Surgery, Vol 46, 283-288, Copyright © 1988 by The Society of Thoracic Surgeons

ARTICLES

Cardiovascular surgery in patients with congenital plasma coagulopathies

JC Vander Woude, JD Milam, WE Walker, DP Houchin, AP Weiland and DA Cooley
Department of Cardiovascular Surgery, Texas Heart Institute, Houston 77225.

From 1978 to 1986, fifteen cardiovascular operations were performed on 13 patients with known congenital bleeding disorders. The patients (10 men and 3 women) had a mean age of 51.1 +/- 3.4 years. Four were seen with cardiovascular lesions and documented hemophilia A (Factor VIII deficiency); 3 had hemophilia B (Factor IX deficiency); 3 had Factor XI deficiency; 2 had von Willebrand's disease, and 1 had dysfibrinogenemia. All patients had a history of major hemorrhage after dental extractions or general surgical procedures, and had clearly documented coagulation disorders on hematological evaluation. Elective cardiovascular procedures performed in these patients included aortocoronary bypass grafting (eight), cardiac valve replacement or repair (five), aortic graft placement (one), and carotid endarterectomy (one). The mainstay of perioperative management included appropriate replacement therapy with blood components. Coagulation factor levels were measured routinely to guide therapy. There were no deaths. Two hemorrhagic complications necessitated reexploration. We conclude that in patients known to have congenital coagulation disorders, cardiovascular operations using systemic heparinization can be performed with minimal morbidity and mortality when carried out with preoperative and perioperative support from the hematology service, adequate replacement therapy using blood components, and careful monitoring of the coagulation status.

This article has been cited by other articles:

				G. J. Despotis, S. A. Santoro, E. Spitznagel, K. M. Kater, J. L. Cox, P. Barnes, and D. G. Lappas Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 271 - 279. [Abstract] [Full Text]